Excluding items, the health insurer earned $2.17 per share, beating the average estimate of $2.08, according to Thomson Reuters I/B/E/S.
Total revenue rose to $46.29 billion from $41.49 billion.
Up to Monday’s close, the company’s shares had gained about 14 percent this year, compared with a 3.7 percent decline in the S and P 500 healthcare index.